Pfizer to Acquire Medivation

Go back to Pfizer to Acquire Medivation

Barclays Downgrades Medivation (MDVN) to Equalweight

August 22, 2016 11:48 AM EDT

Barclays downgraded Medivation (NASDAQ: MDVN) from Overweight to Equalweight.

For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.

Shares of Medivation closed at $67.16 yesterday.

... More